MyAllies NewsBreakingRegulatoryWorldTechnologyBusinessPoliticsEntertainmentHealthSportsTopics
Home › Regulatory

Emergent BioSolutions Inc. - 10-Q Filing

Emergent BioSolutions reports Q3 2026 results amid ongoing organizational restructuring and asset disposal activities.

3 articles from 1 source · updated November 4, 2026, 21:09 UTC

Coverage

  • Emergent BioSolutions Inc. - 8-K Filing SEC EDGAR · November 4, 2026, 21:06 UTC
  • Huron Consulting Group Inc. - 10-Q Filing SEC EDGAR · November 3, 2026, 21:13 UTC
  • Emergent BioSolutions Inc. - 10-Q Filing SEC EDGAR · November 3, 2026, 12:42 UTC